에 대한 최신 뉴스 Compass Pathways (NASDAQ:CMPS) 주식

COMPASS PATHWAYS PLC

Compass Pathways

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

COMPASS Pathways Plc - American Depository Shares

Compass Pathways PLC

Press Releases

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

CMPS

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Annexon

Candel Therapeutics

Cardiff Oncology

Cargo Therapeutics

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Design Therapeutics

Foghorn Therapeutics

Genfit

Immutep Limited - American Depositary Shares

Immutep

Inhibrx Biosciences

Inozyme Pharma

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Monopar Therapeutics

Nanobiotix

Neurogene

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Tevogen Bio Holdings

Vanda Pharmaceuticals Inc. - Common Stock

Comments

Compass Pathways

뉴스

에 대한 최신 뉴스 Compass Pathways (NASDAQ:CMPS) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌